Psychological Distress in Women at Risk of Hereditary Breast/ovarian or HNPCC Cancers in the Absence of Demonstrated Mutations

Overview

Journal Fam Cancer

Publisher Springer

Specialty Oncology

Date 2005 Jun 14

PMID 15951962

Citations 16

Authors

Amy Ostertun Geirdal

Jon G Reichelt

Alv A Dahl

Ketil Heimdal

Lovise Maehle

Astrid Stormorken

Pal Moller

Affiliations

Soon will be listed here.

Abstract

Aim: To examine psychological distress in women at risk of familial breast-ovarian cancer (FBOC) or hereditary non-polyposis colorectal cancer (HNPCC) with absence of demonstrated mutations in the family (unknown mutation).

Materials And Methods: Two-hundred and fifty three consecutive women at risk of FBOC and 77 at risk of HNPCC and with no present or past history of cancer. They were aware of their risk and had received genetic counseling. Comparisons were made between these two groups, normal controls, and women who were identified to be BRCA1 mutation carriers. The questionnaires Beck Hopelessness Scale (BHS), General Health Questionnaire (GHQ-28), Hospital Anxiety and Depression Scale (HADS) and Impact of Event Scale (IES) were employed to assess psychological distress.

Results: No significant differences concerning psychological distress were observed between women with FBOC and women with HNPCC. Compared to mutation carriers for BRCA1, the level of anxiety and depression was significantly higher in the FBOC group with absence of demonstrated mutation. Compared to normal controls, the level of anxiety was higher, while the level of depression was lower in the groups with unknown mutation.

Conclusions: Women in the absence of demonstrated mutations have higher anxiety and depression levels than women with known mutation-carrier status. Access to genetic testing may be of psychologically benefit to women at risk for FBOC or HNPCC.

Citing Articles

The ENGAGE study: a 3-arm randomized hybrid type 1 effectiveness and implementation study of an in-home, collaborative PCP model of remote telegenetic services to increase uptake of cancer genetic services in childhood cancer survivors.

Henderson T, Allen M, Mim R, Egleston B, Fleisher L, Elkin E BMC Health Serv Res. 2024; 24(1):253.

PMID: 38414045 PMC: 10900774. DOI: 10.1186/s12913-024-10586-z.

Assessing Psychological Morbidity in Cancer-Unaffected Pathogenic Variant Carriers: A Systematic Review.

Isselhard A, Lautz Z, Rhiem K, Stock S Curr Oncol. 2023; 30(4):3590-3608.

PMID: 37185387 PMC: 10136916. DOI: 10.3390/curroncol30040274.

Desire for Children and Distress in Women with Hereditary Cancer Syndromes.

Kastner A, Kocak H, Fischer-Jacobs J, Hahne A, Zimmermann T Int J Environ Res Public Health. 2022; 19(21).

PMID: 36361396 PMC: 9654350. DOI: 10.3390/ijerph192114517.

Experience of Norwegian Female BRCA1 and BRCA2 Mutation-Carrying Participants in Educational Support Groups: a Qualitative Study.

Myklebust M, Gjengedal E, Stromsvik N J Genet Couns. 2016; 25(6):1198-1206.

PMID: 27091466 DOI: 10.1007/s10897-016-9954-9.

The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome.

Moldovan R, Keating S, Clancy T Fam Cancer. 2014; 14(1):51-60.

PMID: 25342222 DOI: 10.1007/s10689-014-9761-0.

References

Moller P, Borg A, Evans D, Haites N, Reis M, Vasen H . Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy. Int J Cancer. 2002; 101(6):555-9. DOI: 10.1002/ijc.10641. View

DiCastro M, Frydman M, Friedman I, Shiri-Sverdlov R, Papa M, Goldman B . Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information. Am J Med Genet. 2002; 111(2):147-51. DOI: 10.1002/ajmg.10550. View

Reichelt J, Heimdal K, Moller P, Dahl A . BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample. Fam Cancer. 2004; 3(1):21-8. DOI: 10.1023/B:FAME.0000026820.32469.4a. View

Cull A, Anderson E, Campbell S, Mackay J, Smyth E, Steel M . The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress. Br J Cancer. 1999; 79(3-4):501-8. PMC: 2362435. DOI: 10.1038/sj.bjc.6690078. View

Bodd T, Reichelt J, Heimdal K, Moller P . Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway. J Genet Couns. 2004; 12(5):405-17. DOI: 10.1023/a:1025864703405. View

Thewes B, Meiser B, Hickie I . Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer. Psychooncology. 2001; 10(6):459-68. DOI: 10.1002/pon.533. View

Baider L, Ever-Hadani P . Psychological distress in healthy women with familial breast cancer: like mother, like daughter?. Int J Psychiatry Med. 2000; 29(4):411-20. DOI: 10.2190/LD2F-ND7R-19JK-WL4G. View

Meiser B, Butow P, Friedlander M, Barratt A, Schnieden V, Watson M . Psychological impact of genetic testing in women from high-risk breast cancer families. Eur J Cancer. 2002; 38(15):2025-31. DOI: 10.1016/s0959-8049(02)00264-2. View

Vasen H, Watson P, Mecklin J, Lynch H . New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999; 116(6):1453-6. DOI: 10.1016/s0016-5085(99)70510-x. View

10.

Aktan-Collan K, Haukkala A, Mecklin J, Uutela A, Kaariainen H . Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. Int J Cancer. 2001; 93(4):608-11. DOI: 10.1002/ijc.1372. View

11.

Collins V, Halliday J, Warren R, Williamson R . Cancer worries, risk perceptions and associations with interest in DNA testing and clinic satisfaction in a familial colorectal cancer clinic. Clin Genet. 2001; 58(6):460-8. DOI: 10.1034/j.1399-0004.2000.580606.x. View

12.

Beck A, Brown G, Berchick R, STEWART B, Steer R . Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry. 1990; 147(2):190-5. DOI: 10.1176/ajp.147.2.190. View

13.

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

14.

Lerman C, Hughes C, Lemon S, Main D, Snyder C, Durham C . What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol. 1998; 16(5):1650-4. DOI: 10.1200/JCO.1998.16.5.1650. View

15.

Sundin E, Horowitz M . Impact of Event Scale: psychometric properties. Br J Psychiatry. 2002; 180:205-9. DOI: 10.1192/bjp.180.3.205. View

16.

Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G . BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA. 1996; 275(24):1885-92. View

17.

Mykletun A, Stordal E, Dahl A . Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatry. 2001; 179:540-4. DOI: 10.1192/bjp.179.6.540. View

18.

Lodder L, Frets P, Trijsburg R, Meijers-Heijboer E, Klijn J, Duivenvoorden H . Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet. 2001; 98(1):15-24. View

19.

Meiser B, Butow P, Barratt A, Schnieden V, Gattas M, Kirk J . Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer. Patient Educ Couns. 2001; 44(3):215-25. DOI: 10.1016/s0738-3991(00)00191-9. View

20.

Broadstock M, Michie S, Gray J, Mackay J, Marteau T . The psychological consequences of offering mutation searching in the family for those at risk of hereditary breast and ovarian cancer--a pilot study. Psychooncology. 2001; 9(6):537-48. DOI: 10.1002/1099-1611(200011/12)9:6<537::aid-pon479>3.0.co;2-u. View